I am confused...Which part is the bad news? Was it about the YOY increasing revenues? The filing of the ANDA in a $700 Million market? That Elite's generics are revenue positive and if they chose to stop all R&D would turn Elite profitable (now that is a real piece of news, just not bad)? Was it that they will be able to file additional ANDAs to continue their increasing generic revenues; and might throw an NDA ADF in the mix? What about having completed work to refile what the FDA wants for approval of SEQUESTOX (AS WOULD HAVE BEEN STATED IN THE CRL,) Was it that they will do all the above and NOT TOUCH LPC MONEY? A veritable wealth of news...AND ALL VERY GOOD.
Not THIS shareholder. Not selling one single share. Not until NH and other insiders sell theirs.... and that isn't happening anytime soon.
Latest fiasco with SequestOx and FDA has tempered NH into becoming even more persistent. Looks like all this puppy talk about Elite not doing this and that is all bark and no bite.